These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9870755)

  • 1. Chemical changes during in vivo degradation of poly(anhydride-imide) matrices.
    Uhrich KE; Ibim SE; Larrier DR; Langer R; Laurencin CT
    Biomaterials; 1998 Nov; 19(22):2045-50. PubMed ID: 9870755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(anhydride-co-imides): in vivo biocompatibility in a rat model.
    Ibim SM; Uhrich KE; Bronson R; El-Amin SF; Langer RS; Laurencin CT
    Biomaterials; 1998 May; 19(10):941-51. PubMed ID: 9690836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model.
    Ibim SE; Uhrich KE; Attawia M; Shastri VR; El-Amin SF; Bronson R; Langer R; Laurencin CT
    J Biomed Mater Res; 1998; 43(4):374-9. PubMed ID: 9855196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation, morphology, and protein expression by osteoblasts cultured on poly(anhydride-co-imides).
    Attawia MA; Herbert KM; Uhrich KE; Langer R; Laurencin CT
    J Biomed Mater Res; 1999; 48(3):322-7. PubMed ID: 10398037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery.
    Hanes J; Chiba M; Langer R
    Biomaterials; 1998; 19(1-3):163-72. PubMed ID: 9678864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications.
    Attawia MA; Uhrich KE; Botchwey E; Fan M; Langer R; Laurencin CT
    J Biomed Mater Res; 1995 Oct; 29(10):1233-40. PubMed ID: 8557725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro bone biocompatibility of poly (anhydride-co-imides) containing pyromellitylimidoalanine.
    Attawia MA; Uhrich KE; Botchwey E; Langer R; Laurencin CT
    J Orthop Res; 1996 May; 14(3):445-54. PubMed ID: 8676258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.
    Chiba M; Hanes J; Langer R
    Biomaterials; 1997 Jul; 18(13):893-901. PubMed ID: 9199758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. II. In vivo degradation.
    Leach KJ; Takahashi S; Mathiowitz E
    Biomaterials; 1998 Nov; 19(21):1981-8. PubMed ID: 9863532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo degradation and elimination of injectable ricinoleic acid-based poly(ester-anhydride).
    Vaisman B; Ickowicz DE; Abtew E; Haim-Zada M; Shikanov A; Domb AJ
    Biomacromolecules; 2013 May; 14(5):1465-73. PubMed ID: 23530926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response.
    Pêgo AP; Van Luyn MJ; Brouwer LA; van Wachem PB; Poot AA; Grijpma DW; Feijen J
    J Biomed Mater Res A; 2003 Dec; 67(3):1044-54. PubMed ID: 14613255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) Copolymers.
    Schmeltzer RC; Uhrich KE
    J Bioact Compat Polym; 2006 Mar; 21(2):123-133. PubMed ID: 23956492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro elimination of aliphatic polyanhydrides.
    Domb AJ; Nudelman R
    Biomaterials; 1995 Mar; 16(4):319-23. PubMed ID: 7772672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters).
    Erdmann L; Uhrich KE
    Biomaterials; 2000 Oct; 21(19):1941-6. PubMed ID: 10941915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biodegradability and biocompatibility evaluation of novel alanine ester based polyphosphazenes in a rat model.
    Sethuraman S; Nair LS; El-Amin S; Farrar R; Nguyen MT; Singh A; Allcock HR; Greish YE; Brown PW; Laurencin CT
    J Biomed Mater Res A; 2006 Jun; 77(4):679-87. PubMed ID: 16514601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics.
    Leong KW; Brott BC; Langer R
    J Biomed Mater Res; 1985 Oct; 19(8):941-55. PubMed ID: 3880353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology.
    Laurencin C; Domb A; Morris C; Brown V; Chasin M; McConnell R; Lange N; Langer R
    J Biomed Mater Res; 1990 Nov; 24(11):1463-81. PubMed ID: 2279981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo Degradation and histocompatibility of a novel class of fluorescent copolyanhydrides, poly{[di(p-carboxyphenyl) succinate]-co-(sebacic anhydride)}.
    Fan J; Li Y; Jiang H; Tang G; Wang L
    Macromol Biosci; 2008 May; 8(5):384-92. PubMed ID: 18383480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and in vitro degradation of a new family of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids.
    Jiang HL; Zhu KJ
    Biomaterials; 2001 Feb; 22(3):211-8. PubMed ID: 11197496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo.
    Harten RD; Svach DJ; Schmeltzer R; Uhrich KE
    J Biomed Mater Res A; 2005 Mar; 72(4):354-62. PubMed ID: 15678485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.